ChartRow logo
Data provided bySource: Twelve Data
Share this page

TECH — Bio-Techne price, chart and key statistics

Technical analysis2
Overlay lines0
Addendum charts0
Data provided bySource: Twelve Data
What would $1,000 invested in TECH be worth today? →
TECH returns: By year · By month · By week · Trailing

Price data

Price
$72.78
YTD price return
+23.75%
YTD total return
+24.29%
Market cap
11.4B
Enterprise value
11.6B
Shares outstanding
157.1M
52W low
$43.20
52W high
$72.83
From 52W high
-0.07%
From 52W low
+68.47%
52W range
100%$43.20–$72.83
Beta
1.28

Volume

Rel volume
0.68×
30D volume
2.9M
30D $ vol
210.5M

Insider trading

Insider net 1W
none
Insider net 1M
none
Insider net 3M
none
Insider net 1Y
−$437K

Form 4 transactions by trade date, as filed; latest on file 2026-05-08.

Fundamentals

Sales (ttm)
1.2B
Sales/share
$7.82
EPS (ttm)
$1.09
FCF (ttm)
308.2M
FCF/share
$1.96
Book value/share
$13.79
Net margin
14.00%
ROE
7.94%
ROA
6.52%
Debt / equity
0.09×
Current ratio
2.28

Growth (CAGR, ttm) · 10Y

Sales
+0.94%+2.40%+4.52%+9.03%
Net income
+120.64%-11.33%-0.53%+5.51%
FCF
+37.58%+12.68%+0.87%+9.39%
Shares
+0.80%-0.23%-0.02%+0.51%

Per-share growth (CAGR, ttm) · 10Y

EPS
+121.79%-10.50%+0.18%+4.97%
Sales/share
+0.14%+2.63%+4.54%+8.48%
FCF/share
+36.49%+12.94%+0.88%+8.84%
Book value/share
+9.30%+2.96%+5.74%+8.68%
Dividend/share
+0.00%+0.00%+0.00%+0.00%
Price
+25.11%+7.43%-10.15%+11.34%
Total return
+25.82%+8.00%-9.74%+11.99%

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)
66.6×
P/OI (ttm)
47.5×
Fwd P/E
31.4×
P/S (ttm)
9.3×
P/B (mrq)
5.3×
P/FCF (ttm)
37.1×
EV/EBITDA (fy)
34.3×
EV/Sales (ttm)
9.4×
FCF yield (ttm)
2.70%
Dividend yield (fwd)Div yield
0.44%
Dividend yield (ttm)
0.44%
Dividend/share (fwd)
$0.32
Buyback yield (realized, 1y)
-0.80%
Shareholder yield (realized, 1y)
-0.22%
Buyback yield (cash, ttm)
0.36%
Shareholder yield (cash, ttm)
0.80%

Vs own 10Y history

P/E
63rd
P/OI
43rd
P/S
37th
P/B
32nd
P/FCF
21st

Bar = where today’s multiple sits in TECH’s own 10-year range:near a decade-low (cheap)→mid-range→near a decade-high (rich).

Performance · price returntotal return · as of 2026-11-06#

Data provided bySource: Twelve Data
1D
+0.17%
5D
+0.17%
1M
+0.48%
3M
+1.22%
YTD
+23.75%
1Y
+25.09%
5Y
-41.46%
1D
+0.17%
5D
+0.17%
1M
+0.48%
3M
+1.34%
YTD
+24.29%
1Y
+25.80%
5Y
-40.11%

Fundamentals#

Revenue

5Y CAGR +5.5%10Y CAGR +9.3%YoY +4.6%
$1.2B TTM$299.7M Q1 '27
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26TTM
Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27

Operating income

5Y CAGR +1.2%10Y CAGR +5.3%YoY −23.2%
$240.8M TTM$36.6M Q1 '27
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26TTM
Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27

EPS (diluted)

5Y CAGR +5.9%10Y CAGR +5.2%YoY −25.0%
$1.09 TTM$0.18 Q1 '27
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26TTM
Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27

Free cash flow

5Y CAGR −3.1%10Y CAGR +7.5%YoY +202.4%
$308.2M TTM$67.2M Q1 '27
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26TTM

TTM: operating cash flow $337.6M, capex −$29.4M

Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27

Q1 2027: operating cash flow $73.1M, capex −$5.9M

Shares (diluted)

5Y −3.0%10Y +5.2%YoY +1.0%
157.4M TTM157.9M Q1 '27
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26TTM
Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27

Dividend per share

5Y CAGR +0.0%10Y CAGR +0.0%YoY +0.0%
$0.32 TTM$0.08 Q1 '27
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26TTM
Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27
Full TECH financials →

Bio-Techne Corp. is a global life sciences company that develops, manufactures, and sells reagents, analytical instruments, and precision diagnostics for research, diagnostic, and bioprocessing applications. Its portfolio supports workflows across basic research, translational science, and clinical decision-making, serving customers in academic laboratories, biotechnology and pharmaceutical development, and diagnostic settings. The company’s products include proteins, antibodies, immunoassays, ELISA kits, molecular diagnostics, spatial biology tools, and specialized instruments used to detect, measure, and analyze biological activity. Bio-Techne also provides custom services such as antibody development, protein degradation solutions, gene engineering, and cell and gene therapy-related services. Through its Protein Sciences and Diagnostics and Spatial Biology businesses, Bio-Techne plays an important role in enabling scientific discovery, biomarker analysis, and laboratory testing across the global healthcare and life sciences market.

Minneapolis, MN·3,000 employees·Biotechnology·bio-techne.com·As of Oct 28, 2026

Recent filings#

All filings and insider trades →

ETFs holding TECH#

29 of the 193 ETFs ChartRow carries live hold TECH. The 8 largest positions, by the weight each fund filed in its latest SEC N-PORT report (Jun 26 to Aug 26).

FundNameFiled weight
IBBiShares Biotechnology ETF0.9%
VBKVanguard Small-Cap Growth ETF0.3%
RSPInvesco S&P 500 Equal Weight ETF0.3%
XLVHealth Care Select Sector SPDR Fund0.2%
VHTVanguard Health Care ETF0.2%
VBVanguard Small-Cap ETF0.1%
IWSiShares Russell Mid-Cap Value ETF0.1%
IWRiShares Russell Midcap ETF0.1%
TickerName1M1D
LLYEli Lilly and Company+16.98%-0.79%
JNJJohnson & Johnson+8.42%+1.43%
ABBVAbbVie Inc.+9.23%+1.07%
MRKMerck & Co. Inc.+3.37%-0.14%
UNHUnitedHealth Group Incorporated Common Stock (DE)+4.74%-0.40%
NVSNovartis AG+15.46%+0.38%
TMOThermo Fisher Scientific Inc.+5.81%+2.63%
AMGNAmgen Inc.+14.36%+0.03%